206 related articles for article (PubMed ID: 26159248)
1. Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.
Orsini RG; Verhoeven RH; Lemmens VE; van Steenbergen LN; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
Eur J Cancer; 2015 Sep; 51(13):1675-82. PubMed ID: 26159248
[TBL] [Abstract][Full Text] [Related]
2. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
[TBL] [Abstract][Full Text] [Related]
3. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort.
You YN; Dozois EJ; Boardman LA; Aakre J; Huebner M; Larson DW
Ann Surg Oncol; 2011 Sep; 18(9):2469-76. PubMed ID: 21448750
[TBL] [Abstract][Full Text] [Related]
4. Colorectal carcinoma in pediatric patients: A comparison with adult tumors, treatment and outcomes from the National Cancer Database.
Poles GC; Clark DE; Mayo SW; Beierle EA; Goldfarb M; Gow KW; Goldin A; Doski JJ; Nuchtern JG; Vasudevan SA; Langer M
J Pediatr Surg; 2016 Jul; 51(7):1061-6. PubMed ID: 26703433
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
[TBL] [Abstract][Full Text] [Related]
6. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy rather than neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer with high tumor burden.
Koca D; Oztop J; Yilmaz U
Hepatogastroenterology; 2012 Oct; 59(119):2151-4. PubMed ID: 22440247
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.
Hyngstrom JR; Hu CY; Xing Y; You YN; Feig BW; Skibber JM; Rodriguez-Bigas MA; Cormier JN; Chang GJ
Ann Surg Oncol; 2012 Sep; 19(9):2814-21. PubMed ID: 22476818
[TBL] [Abstract][Full Text] [Related]
9. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
[TBL] [Abstract][Full Text] [Related]
10. Are survival rates different for young and older patients with rectal cancer?
O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
[TBL] [Abstract][Full Text] [Related]
11. Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
Becerra AZ; Wexner SD; Dietz DW; Xu Z; Aquina CT; Justiniano CF; Swanger AA; Temple LK; Noyes K; Monson JR; Fleming FJ
Ann Surg Oncol; 2018 Aug; 25(8):2332-2339. PubMed ID: 29850952
[TBL] [Abstract][Full Text] [Related]
12. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the rectum in patients under age 40 is increasing: impact of signet-ring cell histology.
Tawadros PS; Paquette IM; Hanly AM; Mellgren AF; Rothenberger DA; Madoff RD
Dis Colon Rectum; 2015 May; 58(5):474-8. PubMed ID: 25850833
[TBL] [Abstract][Full Text] [Related]
14. Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.
van Erning FN; Rutten HJ; van den Berg HA; Lemmens VE; van Halteren HK
Eur J Surg Oncol; 2015 Dec; 41(12):1630-5. PubMed ID: 26437853
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of signet ring cell rectal carcinoma.
Chen JS; Hsieh PS; Hung SY; Tang R; Tsai WS; Changchien CR; Lin PY; Wang JY; Yeh CY
Int J Colorectal Dis; 2004 Mar; 19(2):102-7. PubMed ID: 14752674
[TBL] [Abstract][Full Text] [Related]
16. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006.
Elferink MA; van Steenbergen LN; Krijnen P; Lemmens VE; Rutten HJ; Marijnen CA; Nagtegaal ID; Karim-Kos HE; de Vries E; Siesling S;
Eur J Cancer; 2010 May; 46(8):1421-9. PubMed ID: 20172711
[TBL] [Abstract][Full Text] [Related]
17. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
[TBL] [Abstract][Full Text] [Related]
19. [The characteristics of the combined and complex treatment of colloid rectal cancer].
Mel'nikov RA; Nosov AA; Kolosov AE
Vopr Onkol; 1992; 38(5):605-10. PubMed ID: 1284456
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
